Home > Healthcare > Medical Devices > Infection Control > Sterility Indicators Market

Sterility Indicators Market Trends

Report ID: GMI3803
Published Date: Sep 2022
Report Format: PDF

Download Free Sample

Sterility Indicators Market Trends

The rising prevalence of hospital acquired infections is predicted to drive up demand for sterility indicators. Citing an instance, each year, at least one in every 25 patients in the U.S. hospitals is diagnosed with some type of HAI, according to the CDC. Improved cognizance about the ability of sterility indicators to avert infections in hospitals is elevating the industry share. To that end, biological indicators (BI) are important for sterilization quality control in hospitals as they precisely detect if the sterilization conditions are optimum to kill the most resistant bacteria.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Sterility indicators market was valued over 790 million in the year 2021 and is anticipated to grow at a CAGR of more than 9% through 2030.

The biological indicators segment accounted for over 58% market in 2021, owing to their ability to detect sufficient criteria for effective elimination of bacteria during sterilization process.

The North America market was valued over USD 267 million in 2021 and is anticipated to record a strong CAGR through 2030, on account of rising geriatric population who are more prone to chronic ailments.

Mesa Laboratories, 3M, Getinge Group, Matachana Group, H.W.Andersen Products Ltd., PMS, gke-GmbH, STERIS plc, Propper Manufacturing CO., Inc., Liofilchem S.r.l. and hermo Fisher Scientific are all the prominent market players.